Mobile

A PHASE 11, RANDOMIZED, DOUBLE-BLÍND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, WORLDWIDE, DOSE-RANGING CLÍNICAL TRIAL WITH A PROOF-OF-CONCEPT LEAD COHORT TO EVALUATE THE SAFETY, TOLERABILITY, ...

Mise à jour : Il y a 4 ans
Référence : PER-036-12

A PHASE 11, RANDOMIZED, DOUBLE-BLÍND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, WORLDWIDE, DOSE-RANGING CLÍNICAL TRIAL WITH A PROOF-OF-CONCEPT LEAD COHORT TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF MK-8457 + MTX IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Liens